Specificity of in vivo tumor rejection assessed by mixing immune spleen cells with target and unrelated tumor cells.
D000818:Animals; D005354:Fibrosarcoma / Q000139:chemically induced / Q000276:immunology* / Q000473:pathology; D006084:Graft Rejection; D007106:Immune Sera; D007116:Immunization, Passive; D007165:Immunosuppression Therapy; D007951:Leukemia, Myeloid / Q000276:immunology* / Q000473:pathology; D008748:Methylcholanthrene; D051379:Mice; D008807:Mice, Inbred BALB C; D009368:Neoplasm Transplantation; D011830:Radiation Effects; D012513:Sarcoma, Experimental / Q000276:immunology; D013154:Spleen / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology; D014184:Transplantation, Homologous
D007106:Immune Sera; D008748:Methylcholanthrene